Shopping Cart
Remove All
Your shopping cart is currently empty
Remetinostat (SHP-141), a hydroxamic acid-based inhibitor of histone deacetylase enzymes, is currently being developed for the treatment of cutaneous T-cell lymphoma.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $30 | Backorder | Backorder | |
| 10 mg | $48 | Backorder | Backorder | |
| 25 mg | $96 | Backorder | Backorder | |
| 50 mg | $156 | Backorder | Backorder | |
| 100 mg | $251 | Backorder | Backorder | |
| 1 mL x 10 mM (in DMSO) | $34 | - | In Stock |
| Description | Remetinostat (SHP-141), a hydroxamic acid-based inhibitor of histone deacetylase enzymes, is currently being developed for the treatment of cutaneous T-cell lymphoma. |
| Synonyms | SHP-141 |
| Molecular Weight | 323.34 |
| Formula | C16H21NO6 |
| Cas No. | 946150-57-8 |
| Smiles | O(C(CCCCCCC(NO)=O)=O)C1=CC=C(C(OC)=O)C=C1 |
| Relative Density. | no data available |
| Color | White |
| Appearance | solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 150 mg/mL (463.91 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.